Literature DB >> 23314660

Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer.

Shahriar Koochekpour1.   

Abstract

Entities:  

Year:  2013        PMID： 23314660      PMCID： PMC3739154          DOI： 10.1038/aja.2012.145

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  8 in total

Review 1.  Application of metabolomics to prostate cancer.

Authors:  Bruce J Trock
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

2.  Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.

Authors:  Pamela M Pollock; Karine Cohen-Solal; Raman Sood; Jin Namkoong; Jeffrey J Martino; Aruna Koganti; Hua Zhu; Christiane Robbins; Izabela Makalowska; Seung-Shick Shin; Yari Marin; Kathleen G Roberts; Laura M Yudt; Amy Chen; Jun Cheng; Arturo Incao; Heather W Pinkett; Christopher L Graham; Karen Dunn; Steven M Crespo-Carbone; Kerine R Mackason; Kevin B Ryan; Daniel Sinsimer; James Goydos; Kenneth R Reuhl; Michael Eckhaus; Paul S Meltzer; William J Pavan; Jeffrey M Trent; Suzie Chen
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

3.  Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.

Authors:  Cecilia L Speyer; Jennifer S Smith; Malathi Banda; John A DeVries; Tassia Mekani; David H Gorski
Journal:  Breast Cancer Res Treat       Date:  2011-06-17       Impact factor: 4.872

Review 4.  Otto Warburg's contributions to current concepts of cancer metabolism.

Authors:  Willem H Koppenol; Patricia L Bounds; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

5.  Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.

Authors:  Jin Namkoong; Seung-Shick Shin; Hwa Jin Lee; Yarí E Marín; Brian A Wall; James S Goydos; Suzie Chen
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

6.  Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.

Authors:  Shahriar Koochekpour; Sunipa Majumdar; Gissou Azabdaftari; Kristopher Attwood; Ray Scioneaux; Dhatchayini Subramani; Charles Manhardt; Giovanni D Lorusso; Stacey S Willard; Hillary Thompson; Mojgan Shourideh; Katayoon Rezaei; Oliver Sartor; James L Mohler; Robert L Vessella
Journal:  Clin Cancer Res       Date:  2012-10-16       Impact factor: 12.531

7.  Plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal with and without added monosodium glutamate.

Authors:  L D Stegink; L J Filer; G L Baker
Journal:  J Nutr       Date:  1982-10       Impact factor: 4.798

8.  Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame.

Authors:  L D Stegink; L J Filer; G L Baker
Journal:  J Nutr       Date:  1983-09       Impact factor: 4.798
  8 in total
  14 in total

Review 1.  Metabotropic glutamate receptors in cancer.

Authors:  Lumeng J Yu; Brian A Wall; Janet Wangari-Talbot; Suzie Chen
Journal:  Neuropharmacology       Date:  2016-02-16       Impact factor: 5.250

2.  Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation.

Authors:  Ling Hao; Yatao Shi; Samuel Thomas; Chad M Vezina; Sagar Bajpai; Arya Ashok; Charles J Bieberich; William A Ricke; Lingjun Li
Journal:  Int J Mass Spectrom       Date:  2018-09-22       Impact factor: 1.986

3.  Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy.

Authors:  Rajakumar Nagarajan; Zohaib Iqbal; Brian Burns; Neil E Wilson; Manoj K Sarma; Daniel A Margolis; Robert E Reiter; Steven S Raman; M Albert Thomas
Journal:  NMR Biomed       Date:  2015-09-07       Impact factor: 4.044

4.  eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells.

Authors:  Xing Hua Tang; Xun Yi Wu; Lan Xu; You Xin Fang; Ping Wang; Guo Xing Zhu; Zhen Hong
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.

Authors:  Desi Shang; Chunquan Li; Qianlan Yao; Haixiu Yang; Yanjun Xu; Junwei Han; Jing Li; Fei Su; Yunpeng Zhang; Chunlong Zhang; Dongguo Li; Xia Li
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 6.  Glutamate and its receptors in cancer.

Authors:  Andrzej Stepulak; Radoslaw Rola; Krzysztof Polberg; Chrysanthy Ikonomidou
Journal:  J Neural Transm (Vienna)       Date:  2014-03-09       Impact factor: 3.575

7.  Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.

Authors:  Sonia C Dolfi; Daniel J Medina; Aparna Kareddula; Bhavna Paratala; Ashley Rose; Jatinder Dhami; Suzie Chen; Shridar Ganesan; Gillian Mackay; Alexei Vazquez; Kim M Hirshfield
Journal:  Oncotarget       Date:  2017-07-04

Review 8.  Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Int J Biol Sci       Date:  2013-08-09       Impact factor: 6.580

9.  Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer.

Authors:  Henry J M Ferguson; Joseph W Wragg; Stephen Ward; Victoria L Heath; Tariq Ismail; Roy Bicknell
Journal:  Oncotarget       Date:  2016-04-12

10.  Blood glutamate scavengers increase pro-apoptotic signaling and reduce metastatic melanoma growth in-vivo.

Authors:  Yona Goldshmit; Rita Perelroizen; Alex Yakovchuk; Evgeni Banyas; Lior Mayo; Sari David; Amit Benbenishty; Pablo Blinder; Moshe Shalom; Angela Ruban
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.